Genomic Revolution Multi-Sector ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (15)

Latest Posts

About This Stock More About This Stock
Don't Look Now, But Cathie Wood's Ark Is Taking On Water
Article By: Tyler Durden
Wednesday, November 24, 2021 6:15 AM EST
Among the biggest losers over the last 48 hour tech stock volatility has been...well, everything in Cathie Wood's "flagship" ARKK portfolio.
In this article: ARKK, ARKG, SARK
Read
Neck Cream Reversal
Article By: Tim Knight
Thursday, November 18, 2021 11:59 AM EST
Cathie Wood's ARKG is down about 50% over the past 9 months.
In this article: ARKG
Read
ETF Battles: Finding The Top Genomics Biotech ETF – A Triple Header Of ARKG Vs IDNA Vs GNOM
Video By: Ron DeLegge
Thursday, October 21, 2021 4:00 PM EST
The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.
In this video: GNOM, ARKG, IDNA
Watch
Small Cap Biotechs Sagging But More Deals Are Likely To Perk Up The Market
Article By: Rod Raynovich
Thursday, September 9, 2021 1:30 PM EST
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.
In this article: IWC, XBI, ARKG Also: CYRX, QDEL, XLB, XLE, XLF, KDMN, CRSP, VCYT
Read
A Comprehensive Guide To Genomic ETFs
Article By: Zacks Investment Research
Sunday, July 11, 2021 1:59 PM EST
Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon make genomics the next big thing in the space.
In this article: GNOM, PBE, ARKG, IDNA, NTLA, CRSP Also: BEAM, EDIT
Read

Latest Tweets for $ARKG

No tweets yet!

PARTNER HEADLINES